Showing 1 - 12 results of 12 for search 'Pavord S', query time: 0.20s
Refine Results
-
1
-
2
The Wellbeing of the Haematology Workforce in the UK by Stewart-Lord A, Appiah B, Das Neves Eusebio C, Wright J, Pavord S, Leary A
Published 2025-04-01Get full text
Article -
3
-
4
Tezepelumab can Restore Normal Lung Function in Patients with Severe, Uncontrolled Asthma: Pooled Results from the PATHWAY and NAVIGATOR Studies by Ian D. Pavord, Christopher E. Brightling, Stephanie Korn, Nicole L. Martin, Sandhia S. Ponnarambil, Nestor A. Molfino, Jane R. Parnes, Christopher S. Ambrose
Published 2025-04-01Get full text
Article -
5
The epithelial era of asthma research: knowledge gaps and future direction for patient care by Christopher E. Brightling, Gianni Marone, Helena Aegerter, Pascal Chanez, Enrico Heffler, Ian D. Pavord, Klaus F. Rabe, Lena Uller, Del Dorscheid, the Epithelial Science Expert Group, Helena Aegerter, Arnaud Bourdin, Christopher E Brightling, Marco Caminati, Pascal Chanez, Del Dorscheid, Julia Eckl-Dorna, Ibon Eguiluz-Gracia, Enrico Heffler, Pieter Hiemstra, Gianni Marone, Oscar Palomares, Ian D. Pavord, Remo Poto, Klaus F. Rabe, Lena Uller, Gilda Varricchi
Published 2024-12-01Get full text
Article -
6
Comparison of vaccine-induced immune thrombocytopenia and thrombosis cases following two adenovirus-vectored COVID-19 vaccines by Rian Van Rampelbergh, Sue Pavord, Luis Anaya-Velarde, Vitalija van Paassen, Karin Hardt, Emiliano Tatar, Javier Ruiz-Guiñazú, Dawn Baumgardner, Valérie Oriol Mathieu, Nicolas Praet, Hendy Kristyanto, Jerald Sadoff, Macaya Douoguih, Yimei Xu, Frank Struyf
Published 2025-05-01Get full text
Article -
7
Dupilumab efficacy in patients with type 2 asthma and early Feno level reductions by Ian D. Pavord, MD, Michael E. Wechsler, MD, William W. Busse, MD, Christian Domingo, MD, Changming Xia, PhD, Rebecca Gall, MD, Nami Pandit-Abid, PharmD, Juby A. Jacob-Nara, MD, DHSc, Amr Radwan, MBBChir, Paul J. Rowe, MD, Yamo Deniz, MD
Published 2025-08-01Get full text
Article -
8
European biologic training course for type 2 inflammation by EUFOREA in 2024: key facts and lessons learned by D. M. Conti, D. M. Conti, D. M. Conti, V. Backer, W. Fokkens, P. Gevaert, A. Peters, G. K. Scadding, G. K. Scadding, I. Pavord, S. Lau, M. Wechsler, M. Wechsler, X. Bertels, X. Bertels, G. Liva, M. Doulaptsi, E. Prokopakis, P. W. Hellings, P. W. Hellings, P. W. Hellings
Published 2024-12-01Get full text
Article -
9
Understanding mechanisms of thrombosis and thrombocytopenia with adenoviral SARS-CoV-2 vaccines: a comprehensive synopsis by Phillip LR Nicolson, Simon T Abrams, Gayatri Amirthalingam, Kevin Brown, Richard J Buka, Mark J Caulfield, Joshua Gardner, David Goldblatt, Charlotte Lovatt, Samantha J Montague, Dean J Naisbitt, Alan Parker, Sue Pavord, Mary E Ramsay, Jonathan AC Sterne, Cathie LM Sudlow, Cheng Hock Toh, Steve P Watson, Guozheng Wang, Angela M Wood, William Whiteley, Munir Pirmohamed
Published 2025-07-01Get full text
Article -
10
Successful awake proning is associated with improved clinical outcomes in patients with COVID-19: single-centre high-dependency unit experience by Najib M Rahman, Gareth Hynes, Ling-Pei Ho, Rob J Hallifax, William G Flight, John M Wrightson, Stephen J Chapman, Nayia Petousi, Mona Bafadhel, Annabel H Nickol, Emily Fraser, Rachel K Hoyles, Ian D Pavord, Anny Sykes, Maxine Hardinge, Chris D Turnbull, Benedict ML Porter, Patrick JD Elder, Sarah B Evans, Rachel Lardner, Kirsty Archer, Henry V Bettinson, Peter Saunders, Alastair Moore, Nicholas P Talbot
Published 2020-09-01Get full text
Article -
11
Identification of immune correlates of fatal outcomes in critically ill COVID-19 patients. by Jonathan Youngs, Nicholas M Provine, Nicholas Lim, Hannah R Sharpe, Ali Amini, Yi-Ling Chen, Jian Luo, Matthew D Edmans, Panagiota Zacharopoulou, Wentao Chen, Oliver Sampson, Robert Paton, William J Hurt, David A Duncan, Anna L McNaughton, Vincent N Miao, Susannah Leaver, Duncan L A Wyncoll, Jonathan Ball, Philip Hopkins, Oxford Immunology Network Covid-19 response T cell Consortium, Oxford Protective T cell Immunology for COVID-19 (OPTIC) Clinical team, Donal T Skelly, Eleanor Barnes, Susanna Dunachie, Graham Ogg, Teresa Lambe, Ian Pavord, Alex K Shalek, Craig P Thompson, Luzheng Xue, Derek C Macallan, Philip Goulder, Paul Klenerman, Tihana Bicanic
Published 2021-09-01Get full text
Article -
12
Improved COVID-19 outcomes in a large non-invasive respiratory support cohort despite emergence of the alpha variant by Najib M Rahman, Robert Wilson, John M Wrightson, Nayia Petousi, Ian Pavord, Mona Bafadhel, Stephen Chapman, Rachel Hoyles, William Flight, Emily Fraser, Annabel Nickol, Dinesh Addala, Radhika Banka, Robert Hallifax, Anny Sykes, John Park, Patrick Elder, Anand Sundaralingam, Maxine Hardinge, Chris D Turnbull, Sarah B Evans, Rachel Lardner, Henry V Bettinson, Peter Saunders, Alastair Moore, Nicholas P Talbot, Maria Tsakok, Anastasia Fries, Simon Couillard, James Melhorn, Timothy Hinks, Andrew Achaiah, Benedict M L Porter, Oliver Smith, Eihab Bedawi, Hannah Danbury, Eric Douglas, Ling Pei Ho, Vishal Nathwani, Shefaly Patel, Hannah Laurenson-Schafer, Francesca Roxburgh, Evie Rothwell
Published 2021-01-01Get full text
Article